Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
Clinical trial NCT01152346 · COMPLETED
Trial details
- NCT number
- NCT01152346
- Sponsor
- Bioniche Pharma USA LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.